Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

181.39
-4.2600-2.29%
Post-market: 181.390.00000.00%19:35 EDT
Volume:639.69K
Turnover:116.25M
Market Cap:10.70B
PE:-55.89
High:187.14
Open:186.21
Low:179.20
Close:185.65
52wk High:191.62
52wk Low:73.16
Shares:58.98M
Float Shares:56.44M
Volume Ratio:1.07
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2456
EPS(LYR):-3.2819
ROE:-25.98%
ROA:-5.18%
PB:15.68
PE(LYR):-55.27

Loading ...

Glaukos Completes Enrollment in Phase 2 Trial of Glk-321 for Demodex Blepharitis

Reuters
·
Jun 25

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of Glk-321 for Demodex Blepharitis

THOMSON REUTERS
·
Jun 25

Glaukos (GKOS) Gets a Buy from BTIG

TIPRANKS
·
Jun 24

Jefferies Remains a Buy on Glaukos (GKOS)

TIPRANKS
·
Jun 23

Glaukos Chief Development Officer Tomas Navratil sells 1,537 shares for $200,155.56

Reuters
·
Jun 19

Glaukos price target raised to $150 from $136 at Needham

TIPRANKS
·
Jun 17

Needham Raises Price Target on Glaukos to $150 From $136, Keeps Buy Rating

MT Newswires Live
·
Jun 17

Glaukos Is Maintained at Buy by Needham

Dow Jones
·
Jun 17

U.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower

Reuters
·
Jun 17

Glaukos Is Maintained at Buy by Citigroup

Dow Jones
·
Jun 11

Glaukos Corp : Citigroup Raises Target Price to $162 From $140

THOMSON REUTERS
·
Jun 11

Glaukos price target raised to $162 from $140 at Citi

TIPRANKS
·
Jun 11

U.S. RESEARCH ROUNDUP-Arthur J. Gallagher & Co, Datadog, Oracle

Reuters
·
Jun 11

Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)

TIPRANKS
·
Jun 10

Glaukos: Buy Rating Reiterated on Robust Pipeline and Multi-Product Growth Drivers; $162 Price Target Unchanged

TIPRANKS
·
Jun 10

Analyst Reiterates Buy on Glaukos, Maintains $136 Price Target Amid Stable LCD Outlook and Long-Term Growth Potential

TIPRANKS
·
Jun 10

Glaukos Price Target Maintained With a $162.00/Share by BTIG

Dow Jones
·
Jun 10

Glaukos (GKOS) Valuation Check As iDose TR Adoption Renews Growth Expectations

Simply Wall St.
·
Jun 10

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

TIPRANKS
·
Jun 07

Glaukos Shareholders Reinforce Board, Pay and Auditor Support

TIPRANKS
·
Jun 04